Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rachel A. F. Wozniak & James V. Aquavella. (2017) Antibiotics in ophthalmology practice. Expert Review of Ophthalmology 12:3, pages 243-250.
Read now
Read now
Wolfgang Haas, Christine M Sanfilippo, Christine K Hesje & Timothy W Morris. (2013) Contribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones. Clinical Ophthalmology 7, pages 821-830.
Read now
Read now
Articles from other publishers (12)
Heybet Kerem PolatNihat Kurt, Eren AytekinYagmur Akdağ ÇaylıSibel Bozdağ PehlivanSema Çalış. (2022)
Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers:
In Vitro
and
Ex Vivo
Evaluation
. Journal of Ocular Pharmacology and Therapeutics.
Crossref
Crossref
Aura Rusu, Ioana-Andreea Lungu, Octavia-Laura Moldovan, Corneliu Tanase & Gabriel Hancu. (2021) Structural Characterization of the Millennial Antibacterial (Fluoro)Quinolones—Shaping the Fifth Generation. Pharmaceutics 13:8, pages 1289.
Crossref
Crossref
H. Kerem Polat, Sibel Bozdağ Pehlivan, Ceren Özkul, Semih Çalamak, Naile Öztürk, Eren Aytekin, Ayşegül Fırat, Kezban Ulubayram, Sibel Kocabeyoğlu, Murat İrkeç & Sema Çalış. (2020) Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation. International Journal of Pharmaceutics 585, pages 119552.
Crossref
Crossref
Usha K. Rout, A.S. Sanket, Brijesh S. Sisodia, Pradyumna K. Mohapatra, Sanghamitra Pati, Rajni Kant & Gaurav R. Dwivedi. (2020) A Comparative Review on Current and Future Drug Targets Against Bacteria & Malaria. Current Drug Targets 21:8, pages 736-775.
Crossref
Crossref
John Osei Sekyere & Daniel Gyamfi Amoako. (2017) Genomic and phenotypic characterisation of fluoroquinolone resistance mechanisms in Enterobacteriaceae in Durban, South Africa. PLOS ONE 12:6, pages e0178888.
Crossref
Crossref
John Osei Sekyere & Daniel G. Amoako. (2017) Carbonyl Cyanide m-Chlorophenylhydrazine (CCCP) Reverses Resistance to Colistin, but Not to Carbapenems and Tigecycline in Multidrug-Resistant Enterobacteriaceae. Frontiers in Microbiology 8.
Crossref
Crossref
Francis S. Mah & Christine M. Sanfilippo. (2016) Besifloxacin: Efficacy and Safety in Treatment and Prevention of Ocular Bacterial Infections. Ophthalmology and Therapy 5:1, pages 1-20.
Crossref
Crossref
Xian-Zhi Li. 2016. Efflux-Mediated Antimicrobial Resistance in Bacteria. Efflux-Mediated Antimicrobial Resistance in Bacteria
731
753
.
Jean Deschênes & Joseph Blondeau. (2015) Besifloxacin in the management of bacterial infections of the ocular surface. Canadian Journal of Ophthalmology 50:3, pages 184-191.
Crossref
Crossref
Xian-Zhi Li, Patrick Plésiat & Hiroshi Nikaido. (2015) The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria. Clinical Microbiology Reviews 28:2, pages 337-418.
Crossref
Crossref
Terrence P. O’Brien. (2012) Besifloxacin Ophthalmic Suspension, 0.6%: a Novel Topical Fluoroquinolone for Bacterial Conjunctivitis. Advances in Therapy 29:6, pages 473-490.
Crossref
Crossref
Christine M. Sanfilippo, Christine K. Hesje, Wolfgang Haas & Timothy W. Morris. (2011) Topoisomerase Mutations That Are Associated with High-Level Resistance to Earlier Fluoroquinolones in <i>Staphylococcus aureus</i> Have Less Effect on the Antibacterial Activity of Besifloxacin. Chemotherapy 57:5, pages 363-371.
Crossref
Crossref